Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Pazopanib With Oral Topotecan in Patients With Metastatic and Non-resectable Soft Tissue and Bone Sarcomas

NCT02357810 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT02357810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02357810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Pazopanib With Oral Topotecan in Patients With Metastatic and Non-resectable Soft Tissue and Bone Sarcomas
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
March 21, 2015
Completion date
October 12, 2021
Enrollment
178 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

adult liposarcoma, metastatic liposarcoma, metastatic osteosarcoma, recurrent adult soft tissue sarcoma, recurrent liposarcoma, recurrent osteosarcoma, stage iv adult soft tissue sarcoma